Search

everythinglearnresearchcommunity

for

Search:↓

Frontal Fibrosing Alopecia is a type of hair loss that mainly affects postmenopausal women, has unclear causes, and lacks evidence-based treatments.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

Rare ovarian tumors can cause increased male hormones in postmenopausal women; surgery is an effective treatment.

Selenzin Peptide Active can effectively treat hair loss in postmenopausal women.

Higher doses of oestradiol implants improve bone density in postmenopausal women.

Frontal Fibrosing Alopecia mainly affects postmenopausal Mexican women, requiring early detection to prevent permanent hair loss.

Eyebrow loss in frontal fibrosing alopecia is common and may be linked to other health issues.

Rare ovarian tumors can cause hyperandrogenism, even if imaging appears normal.

Rare ovarian tumors can cause hyperandrogenism, even if imaging appears normal.

A rare ovarian tumor caused high testosterone in a postmenopausal woman, resolved by surgery.

Bilateral salpingo-oophorectomy resolved hyperandrogenism in a postmenopausal woman with rare ovarian tumors.

Leydig cell tumors can cause high testosterone and symptoms like hair loss in postmenopausal women, but surgery can improve these symptoms.

Oral dutasteride can potentially treat frontal fibrosing alopecia in postmenopausal women, with some patients showing disease arrest and hair regrowth.

A woman's high testosterone levels and related symptoms improved after ovary removal surgery.

After menopause, some women lose scalp hair and gain facial hair, with patterns suggesting different underlying causes.

Snail1 may contribute to fibrosis in frontal fibrosing alopecia in postmenopausal women.

New treatments for Frontal Fibrosing Alopecia show promise, especially finasteride and dutasteride, with most patients seeing improvement or stabilization.

A woman developed male traits from accidental contact with her husband's testosterone gel.

Evaluate postmenopausal women with high androgen levels using medical history, physical exams, lab tests, and imaging to manage health risks.

Finasteride 5 mg/day effectively treats hair loss in postmenopausal women without hyper-androgenism.

The document concludes that hair loss in women can be treated with topical treatments or hormone therapy depending on the cause.

An ovarian tumor caused a woman's male-like symptoms, which improved after surgery.

The woman's surgery lowered her testosterone and improved scalp hair loss but did not change her excessive body hair.

Taking biotin can lead to incorrect low results in free testosterone tests.

Finasteride can slow hair loss and promote growth in postmenopausal women.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Smoking doesn't cause or prevent Frontal Fibrosing Alopecia, hormonal imbalance may be involved, and a combination of antiandrogens and steroids can help stabilize the condition.

Men and premenopausal women in Korea show different patterns in iron and vitamin D levels, with no clear pattern for postmenopausal women.